<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peroxisome proliferator-activated receptor gamma coactivator-1 (<z:chebi fb="6" ids="26336">PGC</z:chebi>-1) is a transcriptional coactivator of peroxisome proliferator-activated receptor gamma and alpha, which play important roles in adipogenesis and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism </plain></SENT>
<SENT sid="1" pm="."><plain>A single nucleotide polymorphism within the coding region of the <z:chebi fb="6" ids="26336">PGC</z:chebi>-1 gene predicts a glycine to serine substitution at amino acid 482 and has been associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in a Danish population </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we examined whether this Gly482Ser polymorphism is associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:hpo ids='HP_0001513'>obesity</z:hpo>, or metabolic predictors of these diseases, in Pima Indians </plain></SENT>
<SENT sid="3" pm="."><plain>There was no association of the Gly482Ser polymorphism with either type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or BMI (n = 984) </plain></SENT>
<SENT sid="4" pm="."><plain>However, among nondiabetic Pima Indians (n = 183-201), those with the Gly/Gly genotype had a lower mean insulin secretory response to intravenous and oral <z:chebi fb="105" ids="17234">glucose</z:chebi> and a lower mean rate of <z:chebi fb="23" ids="18059">lipid</z:chebi> oxidation (over 24 h in a respiratory chamber) despite a larger mean subcutaneous abdominal adipocyte size and a higher mean plasma free fatty acid concentration </plain></SENT>
<SENT sid="5" pm="."><plain>These data indicate that the Gly482Ser missense polymorphism in <z:chebi fb="6" ids="26336">PGC</z:chebi>-1 has metabolic consequences on <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism that could influence insulin secretion </plain></SENT>
</text></document>